Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of death. [electronic resource]
- Annals of hematology Apr 2015
- S209-18 p. digital
Antineoplastic Agents--therapeutic use Cause of Death Humans Leukemia, Myelogenous, Chronic, BCR-ABL Positive--diagnosis Practice Guidelines as Topic Prognosis Proportional Hazards Models Protein Kinase Inhibitors--therapeutic use Protein-Tyrosine Kinases--antagonists & inhibitors Remission Induction Risk Assessment--methods